Presbyopia correction in conjunction with cataract surgery has been the holy grail for cataract surgeons. Today, several multifocal (bifocal / trifocal) IOLs are available that give excellent unaided visual acuity for distance, intermediate and near vision activities. However, inherent compromises of photic phenomena and reduction in contrast sensitivity often mar the successful visual outcomes of diffractive multifocal IOLs. This has been a concern, particularly in eyes with pre-existing early, stable macular degeneration. More surgeons today prefer monofocal IOL implantation in eyes with mild retinal compromise, including early dry macular degeneration. However, recently, the non-diffractive extended range of vision IOL (Vivity) has been launched. It provides greater spectacle independence compared to monofocal IOLs and available reports show minimal to no photic phenomena as well as contrast sensitivity reduction. However, it is not yet clear whether the Vivity IOL will offer a comparable quality of distance vision and a greater range of vision without significant compromise in the quality of vision in eyes with early dry macular degeneration. The aim of this study is to evaluate unaided and best corrected visual acuity at different distances and varying contrast levels.